E. Ruth Plummer
Impact in
-
- PARP inhibition in cancer therapy
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 3
- Cutaneous Melanoma Detection and Management 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- A. Hilary Calvert (5 shared papers)Alan V. Boddy (4 shared papers)Nicola J. Curtin (4 shared papers)Melanie J. Griffin (2 shared papers)Donald L. Bissett (1 shared paper)Richard John Edmondson (2 shared papers)James T. Cassidy (1 shared paper)Lesley Robson (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)British Journal of Cancer (3 papers)Molecular Cancer Therapeutics (2 papers)British Journal of Radiology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
E. Ruth Plummer
15 papers receiving 425 citations
Peers
Comparison fields: 5 of 63
- Oncology 158
- Biomaterials 69
- Genetics 50
- Cancer Research 64
- Reproductive Medicine 33
Countries citing papers authored by E. Ruth Plummer
This map shows the geographic impact of E. Ruth Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ruth Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ruth Plummer more than expected).
Fields of papers citing papers by E. Ruth Plummer
This network shows the impact of papers produced by E. Ruth Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ruth Plummer. The network helps show where E. Ruth Plummer may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Ruth Plummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 94 | |
| 2 | 2009 | 84 | |
| 3 | 2011 | 48 | |
| 4 | 2015 | 40 | |
| 5 | A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. | 2007 | 33 |
| 6 | 2010 | 28 | |
| 7 | 2014 | 24 | |
| 8 | 2005 | 19 | |
| 9 | 2000 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2008 | 15 | |
| 12 | A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors | 1999 | 7 |
| 13 | Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide | 2005 | 6 |
| 14 | Poly(ADP-ribose) polymerase-1 (PARP-1) genomics in relation to activity in healthy volunteers and cancer patients | 2008 | 2 |
| 15 | 2023 | 1 |
About E. Ruth Plummer
E. Ruth Plummer is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Reproductive Medicine and Dermatology, having authored 15 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), PARP inhibition in cancer therapy (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer therapeutics and mechanisms (2 papers), Cutaneous Melanoma Detection and Management (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (158 citations), Biomaterials (69 citations), Genetics (50 citations), Cancer Research (64 citations) and Reproductive Medicine (33 citations). E. Ruth Plummer has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include A. Hilary Calvert, Alan V. Boddy, Nicola J. Curtin, Melanie J. Griffin, Donald L. Bissett, Richard John Edmondson, James T. Cassidy, Lesley Robson, Mark W. Verrill and Julieann Sludden. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer, Molecular Cancer Therapeutics, British Journal of Radiology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.